Can Plastic Waste Be Transformed Into Food for Humans?
Using bacteria to take a bite out of plastic pollution is not new. But can the same microbes be used as a food source?
Read more...Using bacteria to take a bite out of plastic pollution is not new. But can the same microbes be used as a food source?
Read more...Quelle surprise! Introducing robots into workplaces slows wage growth, particularly among factory labor.
Read more...On Intel’s storied history and self-destruction via greed, and now US stealthy financial support with no accountability.
Read more...Using data across US commuting zones over the period 2000-2020, this column presents evidence that AI adoption has reduced employment, except in high-paying occupations and those requiring a degree in STEM disciplines
Read more...A closer look at “algorithmic wage discrimination” used at gig companies (and increasingly across all industries), one potential tool to stop it, and how the FTC is zeroing in on the practice.
Read more...A new study by the Financial Times on the early results from Biden Administration IRA spending raises as many questions as it answers.
Read more...If you have shopped at Kroger, please consider boycotting them over them over their surge pricing grifting plans.
Read more...Another sober take on near and perhaps intermediate-term electric vehicle prospects.
Read more...Ed Zitron explains in gory detail why OpenAI looks like the mother of all bezzles.
Read more...Why Intel’s prospects are even worse than its stock price plunge and worried press accounts suggest.
Read more...A discussion of the regulatory and behavioral issues that helped produce the Crowdstrike 404.
Read more...A proposed Department of Energy initiative show the US is unserious about either curbing AI energy demand or managing the impact on the grid
Read more...Yes, Virginia, AI, like older forms of automated trading, has a nasty propensity to cause crises.
Read more...Oopsie! US semiconductor protectionism looks to have reduced the size of the pool of needed workers and experts.
Read more...More evidence that US drug price curbs are unlikely to be harming pharmaceutical innovation
Read more...